D-1168-2022 Class I Terminated
FDA drug recall D-1168-2022 was initiated by Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy on April 15, 2022 and is designated Class I. Reason for recall: Subpotent drug The recall status is terminated (terminated November 7, 2022). Affected quantity: 950 mLs in 1x8 oz and 2x16 oz bottles..
Recall Details
- Product Type
- Drugs
- Report Date
- June 15, 2022
- Initiation Date
- April 15, 2022
- Termination Date
- November 7, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 950 mLs in 1x8 oz and 2x16 oz bottles.
Product Description
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
Reason for Recall
Subpotent drug
Distribution Pattern
CA
Code Information
Lot #: 04272022@35, BUD: 7/7/2022.